The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review


Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Vitrectomy


High impact information on Vitrectomy

  • One case was successfully treated with vitrectomy and intravitreal injection of amphotericin B [6].
  • For this purpose, we studied 20 diabetic patients (5 IDDM and 15 NIDDM) with PDR in whom a vitrectomy was performed (group A) [7].
  • Four women underwent strabismus surgery, two had phacoemulsification, and four had vitrectomy [8].
  • METHODS: Material obtained from horses treated for spontaneous disease by therapeutic routine vitrectomy was analyzed for total IgG content and IgG specific for S-Antigen (S-Ag) and interphotoreceptor retinoid-binding protein (IRBP) [9].
  • RESULTS: Mouse embryo fibroblasts derived from PDGF receptor knock-out embryos that do not express either of the two PDGF receptors induced PVR poorly when injected into the eyes of rabbits that had previously undergone gas vitrectomy [10].

Chemical compound and disease context of Vitrectomy


Biological context of Vitrectomy


Anatomical context of Vitrectomy


Associations of Vitrectomy with chemical compounds


Gene context of Vitrectomy


Analytical, diagnostic and therapeutic context of Vitrectomy


  1. Oncofetal fibronectin in diabetic retinopathy. Khan, Z.A., Cukiernik, M., Gonder, J.R., Chakrabarti, S. Invest. Ophthalmol. Vis. Sci. (2004) [Pubmed]
  2. Simplification of glutathione-bicarbonate-Ringer solution: its effect on corneal thickness. McEnerney, J.K., Peyman, G.A. Invest. Ophthalmol. Vis. Sci. (1977) [Pubmed]
  3. Surgical repair of full-thickness idiopathic macular holes associated with significant macular drusen. Berinstein, D.M., Hassan, T.S., Williams, G.A., Margherio, R.R., Ruby, A.J., Garretson, B.R. Ophthalmology (2000) [Pubmed]
  4. Sulfur and calcific keratopathy associated with retinal detachment surgery and vitrectomy. Grossniklaus, H.E., Wood, W.J., Bargeron, C.B., Green, W.R. Ophthalmology (1986) [Pubmed]
  5. Invasive infections due to Candida krusei: report of ten cases of fungemia that include three cases of endophthalmitis. McQuillen, D.P., Zingman, B.S., Meunier, F., Levitz, S.M. Clin. Infect. Dis. (1992) [Pubmed]
  6. Postpartum Candida endophthalmitis. Cantrill, H.L., Rodman, W.P., Ramsay, R.C., Knobloch, W.H. JAMA (1980) [Pubmed]
  7. Vitreous levels of vascular endothelial growth factor are not influenced by its serum concentrations in diabetic retinopathy. Burgos, R., Simó, R., Audí, L., Mateo, C., Mesa, J., García-Ramírez, M., Carrascosa, A. Diabetologia (1997) [Pubmed]
  8. Identification of estrogen and progesterone receptor mRNA expression in the conjunctiva of premenopausal women. Fuchsjäger-Mayrl, G., Nepp, J., Schneeberger, C., Sator, M., Dietrich, W., Wedrich, A., Huber, J., Tschugguel, W. Invest. Ophthalmol. Vis. Sci. (2002) [Pubmed]
  9. Immune responses to retinal autoantigens and peptides in equine recurrent uveitis. Deeg, C.A., Kaspers, B., Gerhards, H., Thurau, S.R., Wollanke, B., Wildner, G. Invest. Ophthalmol. Vis. Sci. (2001) [Pubmed]
  10. Platelet-derived growth factor plays a key role in proliferative vitreoretinopathy. Andrews, A., Balciunaite, E., Leong, F.L., Tallquist, M., Soriano, P., Refojo, M., Kazlauskas, A. Invest. Ophthalmol. Vis. Sci. (1999) [Pubmed]
  11. Epidemic postsurgical Candida parapsilosis endophthalmitis. Clinical findings and management of 15 consecutive cases. Stern, W.H., Tamura, E., Jacobs, R.A., Pons, V.G., Stone, R.D., O'Day, D.M., Irvine, A.R. Ophthalmology (1985) [Pubmed]
  12. Rubeosis iridis: preoperative iris fluorescein angiography and periocular steroids. Ehrenberg, M., McCuen, B.W., Schindler, R.H., Machemer, R. Ophthalmology (1984) [Pubmed]
  13. Effects of intraocular bubble duration in the treatment of macular holes by vitrectomy and transforming growth factor-beta 2. Thompson, J.T., Glaser, B.M., Sjaarda, R.N., Murphy, R.P., Hanham, A. Ophthalmology (1994) [Pubmed]
  14. Surgical management of retinal detachments related to coloboma of the choroid. Gopal, L., Badrinath, S.S., Sharma, T., Parikh, S.N., Shanmugam, M.S., Bhende, P.S., Agrawal, R., Deshpande, D.A. Ophthalmology (1998) [Pubmed]
  15. 5-fluorouracil: new applications in complicated retinal detachment for an established antimetabolite. Blumenkranz, M., Hernandez, E., Ophir, A., Norton, E.W. Ophthalmology (1984) [Pubmed]
  16. Silicone oil in the repair of pediatric complex retinal detachments: a prospective, observational, multicenter study. Scott, I.U., Flynn, H.W., Azen, S.P., Lai, M.Y., Schwartz, S., Trese, M.T. Ophthalmology (1999) [Pubmed]
  17. Kinetics of intraocular gases. Disappearance of air, sulfur hexafluoride, and perfluoropropane after pars plana vitrectomy. Thompson, J.T. Arch. Ophthalmol. (1989) [Pubmed]
  18. Penetration of gentamicin and ofloxacin in human vitreous after systemic administration. Verbraeken, H., Verstraete, A., Van de Velde, E., Verschraegen, G. Graefes Arch. Clin. Exp. Ophthalmol. (1996) [Pubmed]
  19. Vitrectomy with fluconazole infusion: retinal toxicity, pharmacokinetics, and efficacy in the treatment of experimental candidal endophthalmitis. Cheng, C.K., Yang, C.H., Hsueh, P.R., Liu, C.M., Lu, H.Y. Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics. (2004) [Pubmed]
  20. A prospective, open-label, dose-escalating study of low molecular weight heparin during repeat vitrectomy for PVR and severe diabetic retinopathy. Lane, R.G., Jumper, J.M., Nasir, M.A., MacCumber, M.W., McCuen, B.W. Graefes Arch. Clin. Exp. Ophthalmol. (2005) [Pubmed]
  21. Characterization of membranes removed during open-sky vitrectomy. Peczon, B.D., Wolfe, J.K., Gipson, I.K., Hirose, T., Buzney, S.M., Schepens, C.L. Invest. Ophthalmol. Vis. Sci. (1983) [Pubmed]
  22. Injection of tissue plasminogen activator into a branch retinal vein in eyes with central retinal vein occlusion. Weiss, J.N., Bynoe, L.A. Ophthalmology (2001) [Pubmed]
  23. High levels of interleukin-12 in the aqueous humor and vitreous of patients with uveitis. el-Shabrawi, Y., Livir-Rallatos, C., Christen, W., Baltatzis, S., Foster, C.S. Ophthalmology (1998) [Pubmed]
  24. New surgical approach for removing massive foveal hard exudates in diabetic macular edema. Takagi, H., Otani, A., Kiryu, J., Ogura, Y. Ophthalmology (1999) [Pubmed]
  25. Staining of vitreous with triamcinolone acetonide in retained lens surgery with phacofragmentation. Kaynak, S., Celik, L., Kocak, N., Oner, F.H., Kaynak, T., Cingil, G. Journal of cataract and refractive surgery. (2006) [Pubmed]
  26. Effect of plasma osmolality and intraocular pressure on fluid movement across the blood-retinal barrier. Tsuboi, S., Pederson, J.E. Invest. Ophthalmol. Vis. Sci. (1988) [Pubmed]
  27. Intraocular concentration and pharmacokinetics of triamcinolone acetonide after a single intravitreal injection. Beer, P.M., Bakri, S.J., Singh, R.J., Liu, W., Peters, G.B., Miller, M. Ophthalmology (2003) [Pubmed]
  28. Effect of intravitreal dexamethasone on ocular histopathology in a rabbit model of endophthalmitis. Maxwell, D.P., Brent, B.D., Diamond, J.G., Wu, L. Ophthalmology (1991) [Pubmed]
  29. Intraoperative fluorescein angiography. Googe, J.M., Bessler, M., Hoskins, J.C., Miller, J.H. Ophthalmology (1993) [Pubmed]
  30. Glaucoma after macular hole surgery. Chen, C.J. Ophthalmology (1998) [Pubmed]
  31. Unbalanced vitreous levels of pigment epithelium-derived factor and vascular endothelial growth factor in diabetic retinopathy. Ogata, N., Nishikawa, M., Nishimura, T., Mitsuma, Y., Matsumura, M. Am. J. Ophthalmol. (2002) [Pubmed]
  32. Immunohistochemical analysis of the internal limiting membrane peeled with infracyanine green. La Heij, E.C., Dieudonné, S.C., Mooy, C.M., Diederen, R.M., Liem, A.T., van Suylen, R.J., Hendrikse, F. Am. J. Ophthalmol. (2005) [Pubmed]
  33. Vitreous opacities and outcome of vitreous surgery in patients with familial amyloidotic polyneuropathy. Koga, T., Ando, E., Hirata, A., Fukushima, M., Kimura, A., Ando, Y., Negi, A., Tanihara, H. Am. J. Ophthalmol. (2003) [Pubmed]
  34. Expression of mRNA coding for TNF alpha, IL-1 beta and IL-6 by cells infiltrating retinal membranes. Limb, G.A., Earley, O., Jones, S.E., LeRoy, F., Chignell, A.H., Dumonde, D.C. Graefes Arch. Clin. Exp. Ophthalmol. (1994) [Pubmed]
  35. Vitreous levels of angiopoietin 2 and vascular endothelial growth factor in patients with proliferative diabetic retinopathy. Watanabe, D., Suzuma, K., Suzuma, I., Ohashi, H., Ojima, T., Kurimoto, M., Murakami, T., Kimura, T., Takagi, H. Am. J. Ophthalmol. (2005) [Pubmed]
  36. Vitreoretinal surgery for cystoid macular edema associated with retinitis pigmentosa. García-Arumí, J., Martinez, V., Sararols, L., Corcostegui, B. Ophthalmology (2003) [Pubmed]
  37. Vitrectomy for diabetic traction retinal detachment using the multiport illumination system. Steinmetz, R.L., Grizzard, W.S., Hammer, M.E. Ophthalmology (2002) [Pubmed]
  38. Outer retina ischemic infarction--a newly recognized complication of cataract extraction and closed vitrectomy. Part 2. An animal model. Parrish, R., Gass, J.D., Anderson, D.R. Ophthalmology (1982) [Pubmed]
  39. Evaluation for cystoid maculopathy after pars plicata lensectomy-vitrectomy for congenital cataracts. Gilbard, S.M., Peyman, G.A., Goldberg, M.F. Ophthalmology (1983) [Pubmed]
WikiGenes - Universities